Implementation of a Patient-centered, Reproductive Planning Decision Support Tool (MyPath) Among Women With Substance Use Disorder in the Immediate Postpartum Period

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorUniversity of Pittsburgh

About this trial

This is a study to determine the effect of a novel patient-centered, reproductive planning decision support tool developed by the research team called MyPath on postpartum contraceptive decision-making among women with SUDs.

Eligibility criteria

Qualifiers

Be greater than or equal to 18 years of age.

Be pregnant with an EGA of 22 to 37 weeks at enrollment.

Plan to deliver at research site.

Meet DSM-5 criteria for a SUD (i.e., opioid, stimulant or other use disorder) and/or have a diagnosis code for a substance use disorder in their medical record.

Disqualifiers

Have had a fetal or neonatal death with their current pregnancy.

Be currently in jail or prison as required by court of law. Persons on probation or in residential facilities do not need to be excluded.

Have any other condition (social or medical) which, in the opinion of the Investigator, would make study participation unsafe, make study participation difficult, and/or complicate data interpretation.

PPC ONLY: Documented tubal ligation or hysterectomy procedures at time of delivery hospitalization

Trial design

Treatments tested in this trial

  • MyPath Intervention
  • Usual care

Treatment groups

400 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Pittsburgh

Lead sponsor

National Institute on Drug Abuse (NIDA)

Collaborator